翻訳と辞書
Words near each other
・ Earl Hindman
・ Earl Hines
・ Earl Hofmann
・ Earl Hogan
・ Earl Holliman
・ Earl Cronan
・ Earl Cunningham
・ Earl Cureton
・ Earl D. Bloom
・ Earl D. Desmond
・ Earl D. Eisenhower
・ Earl D. Hall
・ Earl D. Johnson
・ Earl D. Morton
・ Earl D. Rainville
Earl Davie
・ Earl Dawson
・ Earl de Grey
・ Earl De La Warr
・ Earl Denman
・ Earl Derr Biggers
・ Earl Desmond
・ Earl Devaney
・ Earl Devore
・ Earl Dew
・ Earl Dewitt Hutto
・ Earl Dittman
・ Earl Dodd
・ Earl Dodge
・ Earl Doherty


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

Earl Davie : ウィキペディア英語版
Earl Davie

Earl Warren Davie (born 1927) is an American biochemist. He is a professor emeritus of biochemistry at the University of Washington. Davie studies the blood proteins involved in coagulation and was among the first scientists to describe the steps of the clotting process. He is a member of the National Academy of Sciences and a fellow of the American Academy of Arts and Sciences.
==Biography==
Davie was born in 1927 in Tacoma, Washington. He received an undergraduate degree from the University of Washington in 1950. He completed a Ph.D. there in 1954.〔(【引用サイトリンク】url=https://depts.washington.edu/biowww/pages/faculty-Davie.shtml )〕 During his doctoral studies, Davie worked with Hans Neurath to learn about protein structure and function. After a postdoctoral fellowship with Fritz Lipmann at Harvard Medical School, Davie worked at the Case Western Reserve University School of Medicine from 1957 to 1962, where he met hematologist Oscar Ratnoff, the discoverer of Hageman factor (later known as factor XII). He then returned to the University of Washington, later chairing the biochemistry department for several years.〔(【引用サイトリンク】url=http://www.thevalleefoundation.org/programs/vvp/earl-w-davie-md-phd )
Davie has made significant research contributions to the understanding of coagulation. Davie and Ratnoff described the sequence of steps in the clotting cascade. Davie and Ratnoff published their clotting cascade model in 1964, around the same time that Robert Gwyn Macfarlane of the University of Oxford produced a similar model. Davie cofounded a biotechnology company, ZymoGenetics, in 1981. The company was purchased by Novo Nordisk several years later; in 2000, ZymoGenetics was recreated as an independent company and it was acquired by Bristol-Myers Squibb in 2010.〔(【引用サイトリンク】url=http://www.bms.com/ourcompany/our_operations/Pages/zymogenetics.aspx )
In 1980, Davie was elected to the National Academy of Sciences.〔(【引用サイトリンク】url=http://www.nasonline.org/member-directory/members/56488.html?referrer=https://www.google.com/ )〕 He was named a fellow of the American Academy of Arts and Sciences in 1987.〔(【引用サイトリンク】url=https://www.amacad.org/content/system/search.aspx?s=earl+davie )〕 In 1993, Davie awarded the Stratton Medal from the American Society of Hematology; he was named a Legend in Hematology by the society in 2008.〔(【引用サイトリンク】url=http://www.hematology.org/About/History/Legends.aspx )〕 The Centre for Blood Research at the University of British Columbia established the Earl W. Davie Symposium in his honor.〔(【引用サイトリンク】url=http://cbr.ubc.ca/events/earl-w-davie-symposium/ )

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「Earl Davie」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.